Form D · Biotechnology

S4 Medical Corp.

Chagrin Falls, OH · CIK 0001852724

Offering snapshot reported Jul 7, 2023 · SEC filing

Reported sold
$5.76M
Offering amount: $7.76M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 23, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 7, 2023Initial$5,762,025No comparison11SEC filing
Mar 29, 2023Initial$745,844No comparison10SEC filing
Apr 8, 2021Amendment$3,024,985$25,000vs Mar 25, 202111SEC filing
Mar 25, 2021Initial$2,999,985No comparison10SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-486174
Total amount sold includes (i) New Cash $4,999,997.25; (ii) $762,028.20 of converted notes; and (iii) warrant to purchase 1 share of Class G common stock

Source: Form D, filed Jul 7, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bill Baumel Director
Emile Daod Director, Executive
Emile Daoud Director, Executive
William Fuller Director, Executive
V. Kadir Kadhiresan Director
Anila Lingamneni Director
Hirak Parikh Director
Roy Tanaka Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
34 South Main, Suite 200
Chagrin Falls, OH, 44022